Literature DB >> 30032346

The Role of the Environment in Eosinophilic Esophagitis.

Paul J Dowling1, Hannah Neuhaus2, Brooke I Polk3.   

Abstract

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated inflammatory disease with incompletely understood pathogenesis. Though disease manifestations were initially ascribed to a delayed reaction to food allergens, emerging evidence suggests that modifiable host factors and environmental allergen exposure may also play critical roles in the pathogenesis and ongoing manifestations of EoE. As with other atopic diseases, lack of early-life exposure to microbial pathogens leads to an immune tolerance defect and reprograms the commensal gut microflora toward a type 2 T helper (Th2) phenotype; the esophageal microbiota, a rich environment consisting of diverse bacterial species, is greatly altered by inflammation. Although multiple early life microbiome-altering factors are associated with EoE development, no causative, direct relationships have been identified. Interestingly, large, cross-sectional analyses of several populations identify an inverse relationship between Helicobacter pylori presence and EoE, likely via virulence factors that downregulate Th2 inflammation, though causality has not been proven. In regard to environmental allergens, some studies support seasonal variation in EoE diagnosis and flares, and EoE can be generated after a large, identifiable aeroallergen exposure. Examples include mouse models of intranasal Aspergillus dosing and following initiation of oral immunotherapy to foods or environmental allergens. Conversely, treatment of allergic rhinoconjunctivitis may improve EoE symptoms, though data is limited to case reports and small series. Unfortunately, biologic therapies for atopic conditions have failed to improve EoE symptoms despite improvement in esophageal eosinophil count, though dupilumab shows promise in ongoing studies. Overall, this chapter shows that EoE pathogenesis is likely multifactorial, and the environment is a key component in our understanding of EoE.

Entities:  

Keywords:  Environment; Eosinophilic esophagitis; Exposure; Microbiome

Mesh:

Substances:

Year:  2019        PMID: 30032346     DOI: 10.1007/s12016-018-8697-9

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  79 in total

1.  Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future.

Authors:  J Stumphy; D Al-Zubeidi; L Guerin; F Mitros; R Rahhal
Journal:  Dis Esophagus       Date:  2010-11-12       Impact factor: 3.429

2.  Commensal bacteria protect against food allergen sensitization.

Authors:  Andrew T Stefka; Taylor Feehley; Prabhanshu Tripathi; Ju Qiu; Kathy McCoy; Sarkis K Mazmanian; Melissa Y Tjota; Goo-Young Seo; Severine Cao; Betty R Theriault; Dionysios A Antonopoulos; Liang Zhou; Eugene B Chang; Yang-Xin Fu; Cathryn R Nagler
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

Review 3.  Immunological mechanisms of sublingual immunotherapy.

Authors:  C A Akdis; I B Barlan; N Bahceciler; M Akdis
Journal:  Allergy       Date:  2006       Impact factor: 13.146

4.  Relationship of pediatric eosinophilic esophagitis diagnosis to pollen and mold counts.

Authors:  Chelsea R Schlegel; Norma M Quintanilla; Anthony P Olive; Charles G Minard; Carla M Davis
Journal:  Ann Allergy Asthma Immunol       Date:  2014-07-02       Impact factor: 6.347

5.  An etiological role for aeroallergens and eosinophils in experimental esophagitis.

Authors:  A Mishra; S P Hogan; E B Brandt; M E Rothenberg
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

6.  De-novo onset of eosinophilic esophagitis after large volume allergen exposures.

Authors:  W Asher Wolf; Maya R Jerath; Evan S Dellon
Journal:  J Gastrointestin Liver Dis       Date:  2013-06       Impact factor: 2.008

7.  Diagnosis of eosinophilic esophagitis in an infant undergoing milk oral immunotherapy - a case report.

Authors:  P Morais Silva; J Antunes; M Chambel; S Prates; P Leiria Pinto
Journal:  Eur Ann Allergy Clin Immunol       Date:  2014-07

Review 8.  Proteases as Th2 adjuvants.

Authors:  Martin D Chapman; Sabina Wünschmann; Anna Pomés
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

9.  Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation.

Authors:  David A Hill; Mark C Siracusa; Michael C Abt; Brian S Kim; Dmytro Kobuley; Masato Kubo; Taku Kambayashi; David F Larosa; Ellen D Renner; Jordan S Orange; Frederic D Bushman; David Artis
Journal:  Nat Med       Date:  2012-03-25       Impact factor: 53.440

Review 10.  Asthma and the microbiome: defining the critical window in early life.

Authors:  Leah T Stiemsma; Stuart E Turvey
Journal:  Allergy Asthma Clin Immunol       Date:  2017-01-06       Impact factor: 3.406

View more
  2 in total

1.  Treatment with compounded fluticasone suspension improves the clinical, endoscopic, and histologic features of eosinophilic esophagitis.

Authors:  Corey J Ketchem; Craig C Reed; Zoe Stefanadis; Evan S Dellon
Journal:  Dis Esophagus       Date:  2021-07-12       Impact factor: 3.429

Review 2.  Eosinophilic esophagitis-established facts and new horizons.

Authors:  Luc Biedermann; Alex Straumann; Thomas Greuter; Philipp Schreiner
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.